Researchers
-
Amaya Peñalva Arigita
Endocrinology and nutrition
-
Gemma Francisco
Endocrinology and nutrition
-
Irela López Cobo
Endocrinology and nutrition
-
Luis Vila Ballester
Endocrinology and nutrition
Phd -
Manuel Sahún De La Vega
Endocrinology and nutrition
Phd -
Maria Lecha
Endocrinology and nutrition
-
Mercè Albareda
Endocrinology and nutrition
Phd -
Mercè Fernández Miró
Endocrinology and nutrition
Phd -
Thank you Lara
Endocrinology and nutrition
-
Raquel Barnes
Endocrinology and nutrition
-
Sara Torrejón Jaramillo
Endocrinology and nutrition
-
Vanesa Cabrejo
Endocrinology and nutrition
Contact the group
Form-
Colom C, Oriola J, Martínez S, Blanco-Vaca F, Casamitjana R, Corcoy R. 1121
Family history in the diagnosis of monogenic diabetes "Leads and misleads".
Hormones (Athens). 2013:12 (3):466-9.
-
Virós D, Camacho M, Zarraonandia I, García J, Quer M, Vila L, León X. 1087
Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy.
Oral Oncol. 2013;49(4):322-5.
Projects
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Multinational, Prospective and Observational Study to Evaluate Uncovered Medical Needs Associated with the Use of Basal Insulin in Patients with Type 2 Diabetes with New or Recent Treatment with Basal Insulin,
-
DISTRICT ATTORNEY:
Sanofi-Aventis, SA
-
TYPE E:
PINE TREE
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Subcutaneous versus intravenous basal insulin in non-critical hospitalized diabetic patients receiving total parenteral nutrition,
-
DISTRICT ATTORNEY:
Andalusian Public Foundation Progress and Health
-
TYPE E:
RD2004
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Subcutaneous versus intravenous basal insulin in non-critical hospitalized diabetic patients receiving total parenteral nutrition,
-
DISTRICT ATTORNEY:
Andalusian Public Foundation Progress and Health
-
TYPE E:
RD2004
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
EUthyroid – Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe (Horizon - European Commission)
-
DISTRICT ATTORNEY:
European Euthyroid Consortium
-
TYPE E:
Horizon SEP-210177284
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Pragmatic real-world trial, 26 weeks with 6 months of extension, randomized, open, with 2 parallel arms, to evaluate the results of the clinical and health benefits of the transition to Toujeo ® compared to standard treatment insulins, in patients with Diabetes Mellitus Type 2 inadequately controlled treated with basal insulin,
-
DISTRICT ATTORNEY:
Sanofi aventis Groupe
-
TYPE E:
RD2004
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Pragmatic real world trial, 26 weeks with 6 months extension, randomised, open, 2 parallel arms, to evaluate the results of the clinical and health benefits of the transition to Toujeo ® compared to standard treatment insulins, in patients with Diabetes Mellitus Type 2 inadequately controlled treated with basal insulin,
-
DISTRICT ATTORNEY:
Sanofi aventis Groupe
-
TYPE E:
RD2004
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Observational study - diagnostic protocol and treatment of thyroid dysfunction in the pregnant population,
-
DISTRICT ATTORNEY:
Sergio Donnay Candil (University Hospital Fundación de Alarcón)
-
TYPE E:
PINE TREE
-
Endocrinology and nutrition
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Preprandial mixed insulins vs bolus-basal insulin therapy in people aged > 65 years with poorly controlled type 2 diabetes with 1-2 doses of insulin,
-
DISTRICT ATTORNEY:
Dr. Mercè Albareda
-
TYPE E:
PI
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Preprandial mixed insulins vs bolus-basal insulin therapy in people aged > 65 years with poorly controlled type 2 diabetes with 1-2 doses of insulin,
-
DISTRICT ATTORNEY:
Dr. Mercè Albareda
-
TYPE E:
PINE TREE
-
Endocrinology and nutrition
Researcher
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Factors predicting the control of Glycated Hemoglobin (HBA1c) and the need for intensification in patients with Diabetes Mellitus Type 2 with controlled fasting glucose values and in treatment with basal insulin,
-
DISTRICT ATTORNEY:
Sanofi Aventis SA
-
TYPE E:
EPA
Lines of action
- Adequacy and effectiveness of primary prevention of arteriosclerotic disease
- Iodine nutrition and thyroid function
- Nutritional support: Nutritional support and education for complex chronic patients and treatment and control of patients with dysphagia
- Impact of hypogonadotropic hypogonadism and its treatment in patients with type 1 diabetes
- Metabolic control and well being in type 1 diabetes
